Mark D. Kent, the President - MSO of $ALHC, bought 14,848 shares of the company on 06-02-2026 for an estimated $197,626. This trade was reported by Quiver Quantitative using data from a recent SEC filing. This increased their holdings of this class of stock by approximately inf%. Following this trade, they now own 14,848 shares of this class of $ALHC stock.
$ALHC Insider Trading Activity
$ALHC insiders have traded $ALHC stock on the open market 58 times in the past 6 months. Of those trades, 1 have been purchases and 57 have been sales.
Here’s a breakdown of recent trading of $ALHC stock by insiders over the last 6 months:
- ATLANTIC, L.P. GENERAL sold 11,119,494 shares for an estimated $206,489,003
- ATLANTIC (ALN HLTH), L.P. GENERAL sold 11,119,494 shares for an estimated $206,489,003
- JOHN E KAO (Chief Executive Officer) has made 0 purchases and 18 sales selling 2,411,593 shares for an estimated $46,201,221.
- DAWN CHRISTINE MARONEY (President) has made 0 purchases and 15 sales selling 956,084 shares for an estimated $18,849,067.
- CHRISTOPHER J JOYCE (Chief Legal and Admin. Officer) has made 0 purchases and 6 sales selling 89,642 shares for an estimated $1,665,606.
- ROBERT L. SCAVO (Chief Information Officer) has made 0 purchases and 5 sales selling 84,870 shares for an estimated $1,575,263.
- ANDREAS P. WAGNER (Chief Human Resources Officer) has made 0 purchases and 4 sales selling 66,958 shares for an estimated $1,273,939.
- HYONG KIM (Chief Medical Officer) has made 0 purchases and 4 sales selling 47,604 shares for an estimated $918,603.
- SEBASTIAN BURZACCHI (COO - Mgmt Services Org) has made 0 purchases and 2 sales selling 27,946 shares for an estimated $516,427.
- JAMES M HEAD (Chief Financial Officer) sold 11,100 shares for an estimated $233,987
- MARK D. KENT (President - MSO) purchased 14,848 shares for an estimated $197,626
To track insider transactions, check out Quiver Quantitative's insider trading dashboard. You can access data on insider stock transactions through the Quiver Quantitative API insider transaction endpoint.
$ALHC Hedge Fund Activity
We have seen 179 institutional investors add shares of $ALHC stock to their portfolio, and 133 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- GENERAL ATLANTIC, L.P. removed 13,167,733 shares (-100.0%) from their portfolio in Q1 2026, for an estimated $232,015,455
- T. ROWE PRICE INVESTMENT MANAGEMENT, INC. removed 10,874,567 shares (-86.5%) from their portfolio in Q4 2025, for an estimated $214,772,698
- CAPITAL RESEARCH GLOBAL INVESTORS added 3,593,576 shares (+inf%) to their portfolio in Q1 2026, for an estimated $63,318,809
- WELLINGTON MANAGEMENT GROUP LLP added 3,028,043 shares (+21.5%) to their portfolio in Q1 2026, for an estimated $53,354,117
- BANK OF NEW YORK MELLON CORP added 2,316,777 shares (+232.5%) to their portfolio in Q1 2026, for an estimated $40,821,610
- DANICA PENSION, LIVSFORSIKRINGSAKTIESELSKAB added 2,000,000 shares (+inf%) to their portfolio in Q4 2025, for an estimated $39,500,000
- BANK OF AMERICA CORP /DE/ added 1,961,778 shares (+156.5%) to their portfolio in Q1 2026, for an estimated $34,566,528
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard. You can access data on hedge funds moves and 13F filings through the Quiver Quantitative API 13F endpoint.
$ALHC Revenue
$ALHC had revenues of $1.2B in Q1 2026. This is an increase of 33.26% from the same period in the prior year.
You can track ALHC financials on Quiver Quantitative's ALHC stock page.
You can access data on ALHC stock through the Quiver Quantitative API.
$ALHC Analyst Ratings
Wall Street analysts have issued reports on $ALHC in the last several months. We have seen 1 firms issue buy ratings on the stock, and 0 firms issue sell ratings.
Here are some recent analyst ratings:
- Piper Sandler issued a "Overweight" rating on 01/06/2026
To track analyst ratings and price targets for $ALHC, check out Quiver Quantitative's $ALHC forecast page.
$ALHC Price Targets
Multiple analysts have issued price targets for $ALHC recently. We have seen 7 analysts offer price targets for $ALHC in the last 6 months, with a median target of $23.0.
Here are some recent targets:
- Andrew Mok from Barclays set a target price of $16.0 on 05/26/2026
- Jonathan Yong from UBS set a target price of $22.0 on 05/01/2026
- John Stansel from JP Morgan set a target price of $26.0 on 02/05/2026
- Ryan Langston from TD Cowen set a target price of $25.0 on 01/16/2026
- Jessica Tassan from Piper Sandler set a target price of $30.0 on 01/06/2026
This article is not financial advice. See Quiver Quantitative's disclaimers for more information.
